Long-acting, injectable drug could strengthen efforts to prevent, treat HIV

Scientists have developed an injectable drug that blocks HIV from entering cells. They say the new drug potentially offers long-lasting protection from the infection with fewer side effects. The drug, which was tested in non-human primates, could eventually replace or supplement components of combination drug “cocktail” therapies currently used to prevent or treat the virus.…

Details

Group of international scientists align on a definition for ‘synbiotic’

The word ‘synbiotic’ appears on a growing number of food and supplement products, with synbiotic ingredients showing promise for modulating the community of microbes living in the human gut, while providing a health benefit. Synbiotics are generally understood to be a combination of a probiotic and a prebiotic–but experts have deemed this description too limiting…

Details

Mass General researchers create bioluminescent tag to detect DNA break repair

BOSTON – A new bioluminescent reporter that tracks DNA double stranded break (DSB) repair in cells has been developed by researchers from Massachusetts General Hospital (MGH) and the Academia Sinica in Taiwan. The international team’s novel bioluminescent repair reporter (BLRR)-based system can be used to monitor DNA repair pathways directly in animals as well as…

Details

Detailed map of natural killer cells in COVID-19 patients expands understanding of innate immune response to SARS-CoV-2

A new study of 27 patients hospitalized with COVID-19 has provided a detailed map of natural killer (NK) cell responses to SARS-CoV-2 infection, revealing that specific characteristics of NK cell activation associate with different levels of disease severity. The findings are consistent with previous reports that NK cells exist in lower frequencies in the blood…

Details

COVID-19 pooling test method from Ben-Gurion U. IDs asymptomatic carriers

BEER-SHEVA, Israel, August 21, 2020 – A new peer-reviewed study published in Science Advances confirms the success of a new COVID-19 pooling test that identifies all positive subjects, including asymptomatic carriers, in a single round of testing. P-BEST, an algorithmic method for pooling-based efficient SARS-CoV-2 testing, was developed by a group of researchers from Ben-Gurion…

Details

Live Covid-19 Coverage: Global Updates

Here’s what you need to know: ImageThe Department of Health and Human Services is giving permission to pharmacists nationwide to administer all scheduled shots, including the flu vaccine, to children as young as 3.Credit…LM Otero/Associated Press U.S. health agencies announce moves to confront the flu season and plummeting child vaccination rates. Two top U.S. health agencies…

Details